Display options
Cite
Sahraean Z, Ayatollahi M, Yaghobi R, et al. Differential Expression of Insulin-Like Growth Factor-I Receptor on Human Bone Marrow-Derived Mesenchymal Stem Cells Induced by Tumor Necrosis Factor-α. Int J Organ Transplant Med. 2014;5(1):15-22
Sahraean, Z., Ayatollahi, M., Yaghobi, R., & Ziaei, R. (2014). Differential Expression of Insulin-Like Growth Factor-I Receptor on Human Bone Marrow-Derived Mesenchymal Stem Cells Induced by Tumor Necrosis Factor-α. International journal of organ transplantation medicine, 5(1), 15-22.
Sahraean, Z, et al. "Differential Expression of Insulin-Like Growth Factor-I Receptor on Human Bone Marrow-Derived Mesenchymal Stem Cells Induced by Tumor Necrosis Factor-α." International journal of organ transplantation medicine vol. 5,1 (2014): 15-22.
Sahraean Z, Ayatollahi M, Yaghobi R, Ziaei R. Differential Expression of Insulin-Like Growth Factor-I Receptor on Human Bone Marrow-Derived Mesenchymal Stem Cells Induced by Tumor Necrosis Factor-α. Int J Organ Transplant Med. 2014;5(1):15-22. PMID: 25013674; PMCID: PMC4089332.
Copy Download .nbib Format: NLM
Share it on

Int J Organ Transplant Med. 2014;5(1):15-22.

Differential Expression of Insulin-Like Growth Factor-I Receptor on Human Bone Marrow-Derived Mesenchymal Stem Cells Induced by Tumor Necrosis Factor-α.

International journal of organ transplantation medicine

Z Sahraean, M Ayatollahi, R Yaghobi, R Ziaei

Affiliations

  1. Department of Biology, Science and Research, Islamic Azad University, Fars, Iran.
  2. Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 25013674 PMCID: PMC4089332

Abstract

BACKGROUND: Cell-based therapy has been implicated in the treatment of liver diseases. Mesenchymal stem cells from various sources such as bone marrow are available. These cells are one of the major candidates in cell therapy. The production of insulin-like growth factor-I increases in the regenerating organ. The insulin-like growth factor-I in liver regeneration is effective after binding to insulin-like growth factor-I receptor.

OBJECTIVE: To test our hypothesis that tumor necrosis factor-α can stimulate mesenchymal stem cells to express insulin-like growth factor-I receptor.

METHODS: Bone marrow was aspirated from normal human donor after taking informed consent. Cells were isolated and cultured. Identification of cells was done by flowcytometry and functional tests. The fourth passage cells were treated with tumor necrosis factor-α at two doses of 1 and 10 ng/mL, and incubated for 2, 10, 24, and 48 hours. Insulin-like growth factor-I receptor gene expression was studied using real-time polymerase chain reaction.

RESULTS: Flowcytometry showed that the human bone marrow mesenchymal stem cells were positive for CD90 and negative for CD45 and CD80. The insulin-like growth factor-I receptor gene expression was increased in tumor necrosis factor-α treated in comparison with untreated cells.

CONCLUSION: Treatment of human bone marrow-derived mesenchymal stem cells with tumor necrosis factor-α increases gene expression of insulin-like growth factor-I receptor. This finding may be used for increasing the effectiveness of stem cell therapy in those with acute hepatic failure.

Keywords: Human bone marrow; Insulin-like growth factor-I; Mesenchymal stem cells; Tumor necrosis factor-α

References

  1. Neuroradiology. 2009 Oct;51(10):661-7 - PubMed
  2. Am J Physiol. 1992 Jul;263(1 Pt 1):L79-87 - PubMed
  3. Trends Immunol. 2004 Jun;25(6):280-8 - PubMed
  4. J Embryol Exp Morphol. 1966 Dec;16(3):381-90 - PubMed
  5. N Engl J Med. 1997 Feb 27;336(9):633-40 - PubMed
  6. Brain Res. 2011 Jan 7;1367:103-13 - PubMed
  7. Stem Cells. 2011 Jan;29(1):5-10 - PubMed
  8. J Leukoc Biol. 2010 Feb;87(2):283-9 - PubMed
  9. J Bone Joint Surg Am. 2003 Aug;85(8):1544-52 - PubMed
  10. Biochem J. 1993 Mar 1;290 ( Pt 2):419-26 - PubMed
  11. Science. 1996 Nov 22;274(5291):1379-83 - PubMed
  12. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1441-6 - PubMed
  13. Biochemistry. 1992 Dec 1;31(47):11801-5 - PubMed
  14. J Korean Med Sci. 2009 Aug;24(4):547-54 - PubMed
  15. Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1283-90 - PubMed
  16. World J Stem Cells. 2012 Jan 26;4(1):1-8 - PubMed
  17. Exp Hematol. 2010 Jul;38(7):574-80 - PubMed
  18. Int J Rheum Dis. 2011 May;14(2):211-5 - PubMed
  19. Blood. 2005 Jul 15;106(2):756-63 - PubMed
  20. Mol Pathol. 2001 Jun;54(3):133-7 - PubMed
  21. FASEB J. 1995 Dec;9(15):1527-36 - PubMed
  22. Nephrology (Carlton). 2007 Feb;12(1):44-52 - PubMed
  23. Exp Biol Med (Maywood). 2006 Jan;231(1):39-49 - PubMed
  24. Endocr Rev. 1989 Feb;10(1):68-91 - PubMed
  25. Endocr Rev. 1995 Feb;16(1):3-34 - PubMed

Publication Types